Increasing postprandial GLP-1 concentrations is a key target for improving metabolic health and/or decreasing obesity risk by stimulating insulin secretion and angiogenesis, whilst suppressing appetite and energy intake [1–3]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.